Ghent, Belgium – June 8, 2026 — MicroPort® MedBot™ announced the successful completion of a robot-assisted telesurgical procedure using the Toumai® surgical robotic system over the Starlink Low Earth Orbit (LEO) satellite network. Performed by robotic urologist Dr. Geert De Naeyer in Belgium, the procedure was completed without network interruption and maintained an end-to-end communication latency of approximately 70 milliseconds.

The milestone further expands the Toumai® system's demonstrated compatibility with a broad range of communication infrastructures, including dedicated fibre networks, 5G, broadband internet, and both geostationary (GEO) and Low Earth Orbit (LEO) satellite networks. Reliable, low-latency connectivity remains a critical requirement for robotic telesurgery, and LEO satellite technology offers an additional option for extending specialist surgical care to rural, mountainous, island, and other underserved regions where terrestrial infrastructure may be limited.

During the procedure, Dr. De Naeyer performed a robot-assisted radical prostatectomy using the Toumai® system. Throughout the operation, communication remained stable and robotic control was maintained without interruption. Dr. De Naeyer and Dr. Edward Lambert, who was located at the patient site, alternated control of the robotic system during the procedure, demonstrating a collaborative workflow that may support remote mentoring, surgical education, and specialist consultation.

Commenting on the achievement, Dr. Geert De Naeyer said:

"Performing this Low Earth Orbit satellite telesurgery with the Toumai® robot in Belgium marks a new chapter in connected surgery. By demonstrating safe and precise surgery over this resilient communication platform, we can help bring expert care closer to patients regardless of their location."

This procedure builds on Toumai®'s growing clinical telesurgery programme across Europe, including collaborations in Belgium, Spain, Germany, France, the United Kingdom, Poland, and Serbia. MicroPort® MedBot™ continues to work with clinical partners to advance robotic-assisted telesurgery across diverse communication networks and healthcare settings.

About MicroPort® MedBot™

Commenced development of laparoscopic surgical robots in 2014 and officially established in Shanghai in 2015, Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort® MedBot™", stock code: 02252.HK), a subsidiary of MicroPort Scientific Corporation ("MicroPort®", stock code: 00853.HK), is currently the only surgical robotics company with businesses spanning five major segments: laparoscopic, orthopedic, vascular interventional, natural orifice, and percutaneous surgical robotics.

MicroPort® MedBot™ integrates robotics, intelligent control, image-guided navigation, and precision imaging technologies to develop intelligent surgical solutions that support minimally invasive care worldwide.

Regulatory Disclaimer

The Toumai® surgical robotic system's regulatory approvals and cleared indications vary by country and region. Not all indications or uses described in this release may be approved in all markets. Healthcare professionals should refer to applicable local regulatory requirements and the product instructions for use.